Central to all three projects — from neuronal imaging in NEURAM/VISGEN to clinical endoscopic imaging in AMPLITUDE.
FEMTONICS KUTATO ES FEJLESZTO KORLATOLT FELELOSSEGU TARSASAG
Hungarian photonics SME developing multi-photon microscopy and Raman spectroscopy instruments for neuroscience research and clinical cancer diagnostics.
Their core work
Femtonics is a Budapest-based SME specializing in advanced optical imaging and spectroscopy instruments, particularly multi-photon microscopy and Raman spectroscopy systems. Their core business revolves around developing high-performance laser-based imaging tools for life science research and clinical diagnostics. In H2020 projects, they contributed photonics hardware and imaging expertise to both fundamental neuroscience research (visualizing neuronal functions in real time) and clinical applications (endoscopic bladder cancer diagnosis). They sit at the intersection of photonics engineering and biomedical application, turning advanced laser physics into practical imaging instruments.
What they specialise in
Listed as core keyword in both NEURAM and VISGEN, indicating instrument development or integration of Raman techniques.
AMPLITUDE project targets bladder cancer diagnosis using multimodal photonics in endoscopy — a clear move from lab to clinic.
AMPLITUDE explicitly lists fibre lasers as a key technology, suggesting Femtonics works with or develops compact laser sources.
NEURAM and VISGEN both focused on visualizing neuronal and nuclear functions in real time using advanced optical methods.
How they've shifted over time
Femtonics began its H2020 participation (2016-2017) focused on fundamental research instrumentation — specifically Raman spectroscopy tools for neuroscience applications through NEURAM and VISGEN, both under the Research Excellence pillar. By 2020, their focus shifted decisively toward clinical translation with the AMPLITUDE project, applying multimodal photonics to bladder cancer detection via endoscopy. This trajectory shows a clear progression from lab-grade research instruments toward medical device applications with direct clinical impact.
Femtonics is moving from pure research instrumentation toward medical-grade imaging devices, suggesting future projects will likely target clinical diagnostics and regulatory-ready photonic tools.
How they like to work
Femtonics has participated exclusively as a partner, never as coordinator — consistent with a technology SME that provides specialized hardware and photonics expertise to research-led consortia. With 29 unique partners across 11 countries in just 3 projects, they operate in medium-to-large consortia and have broad exposure to different European research groups. This profile suggests they are a sought-after instrument provider rather than a project initiator, making them a reliable technical contributor to bring into a consortium.
Despite only 3 projects, Femtonics has built a wide network of 29 partners across 11 countries, indicating participation in large international consortia. Their reach spans well beyond Central Europe, covering a broad cross-section of EU research institutions and companies.
What sets them apart
Femtonics combines photonics instrument manufacturing with deep application knowledge in both neuroscience and clinical diagnostics — a rare combination for an SME. Their transition from lab-only Raman spectroscopy tools to endoscopic cancer detection systems shows they can bridge the gap between fundamental research and clinical use. For consortium builders, they offer a Hungarian SME with real hardware development capability, not just consultancy — they build the instruments that generate the data.
Highlights from their portfolio
- NEURAMLargest project by far (EUR 1.86M to Femtonics alone), focused on real-time visualization of neuronal nuclear functions — a technically demanding application of their imaging systems.
- AMPLITUDEMarks Femtonics' pivot into clinical diagnostics, applying multimodal photonics to bladder cancer detection via endoscopy — their most commercially oriented H2020 project.